JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ahmet Feridun Isik
Bulent Tuncozgur
Levent Elbeyli
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Sanli, M.
Right arrow Articles by Elbeyli, L.
PubMed
Right arrow Articles by Sanli, M.
Right arrow Articles by Elbeyli, L.
Related Collections
Right arrow Lung - cancer
Right arrow Mediastinum

J Thorac Cardiovasc Surg 2009;138:1200-1205
© 2009 The American Association for Thoracic Surgery


General Thoracic Surgery

Reliability of positron emission tomography–computed tomography in identification of mediastinal lymph node status in patients with non–small cell lung cancer

Maruf Sanli, MDa,*, Ahmet Feridun Isik, MDa, Sabri Zincirkeser, MDb, Osman Elbek, MDc, Ahmet Mete, MDd, Bulent Tuncozgur, MDa, Levent Elbeyli, MDa

a Thoracic Surgery Department, Gaziantep University, School of Medicine, Gaziantep, Turkey
b Nuclear Medicine Department, Gaziantep University, School of Medicine, Gaziantep, Turkey
c Chest Disease Department, Gaziantep University, School of Medicine, Gaziantep, Turkey
d Radiology Department, Gaziantep University, School of Medicine, Gaziantep, Turkey

Received for publication September 1, 2008; revisions received February 24, 2009; accepted for publication March 23, 2009.

* Address for reprints: Maruf Sanli, MD, Gaziantep Üniversitesi, Tip Fakültesi, Gögüs Cerrahisi AD, 27310-Sehitkamil/Gaziantep/Turkey. (Email: sanli{at}gantep.edu.tr).

Objective: The involvement of mediastinal lymph nodes is a very important prognostic factor in patients with potentially resectable non–small cell lung cancer. Our aim in this study was to investigate the value of positron emission tomographic–computed tomographic scanning in staging lung cancer, especially for mediastinal lymph node evaluation, and to determine whether this could decrease the need for mediastinoscopy.

Methods: Seventy-eight patients with non–small cell lung cancer who were potential candidates for surgical resection and admitted to the thoracic surgery unit of our hospital from March 2006 to June 2008 joined this prospective study. Positron emission tomographic–computed tomographic scanning was performed as part of the prospective studies used to diagnose or stage the tumors. All 78 patients underwent tissue sampling of mediastinal lymph nodes to compare these with imaging results. The diagnostic efficacy of the computed tomographic and positron emission tomographic–computed tomographic scans compared with histopathologic findings were calculated with sensitivity, specificity, positive and negative predictive values, and accuracy.

Results: Final histology was available on 397 lymph node stations (N1, N2, and N3) sampled from 78 patients during mediastinoscopy or surgical intervention. Sensitivity, specificity, and positive and negative predictive values of mediastinal lymph node involvement in patients undergoing thoracic computed tomographic scanning were 45.4%, 80.5%, 27.7%, and 90%, respectively. The accuracy of computed tomographic scanning was 75.6%. The sensitivity, specificity, and positive and negative predictive values of mediastinal lymph node involvement in patients undergoing positron emission tomographic–computed tomographic scanning were 81.8%, 89.5%, 56.2%, and 96.7%, respectively.

Conclusion: There is a need for mediastinoscopy in positron emission tomographic–computed tomographic scanning–positive mediastinal lymph nodes, but it might not be necessary for positron emission tomographic–computed tomographic scanning–negative lymph nodes.



Abbreviations and Acronyms CT = computed tomography; EBUS–FNA = endobronchial ultrasound-guided fine-needle aspiration; EUS–FNA = endoscopic ultrasound-guided fine-needle aspiration; FDG = [18F]-2-fluoro-2-deoxy-D-glucose; FNA = fine-needle aspiration; MLN = mediastinal lymph node; NSCLC = non–small cell lung cancer; PET = positron emission tomography; SUV = standardized uptake value








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.